{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:54:28Z","timestamp":1771026868231,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Only a few cases of extranodal Epstein-Barr virus (EBV)-associated B-cell lymphomas arising from patients with angioimmunoblastic T-cell lymphoma (AITL) have been described. We report a case of AITL of which secondary cutaneous EBV-associated diffuse large B-cell lymphoma (DLBCL) developed after the initial diagnosis of AITL. A 65-year-old Chinese male patient was diagnosed as AITL based on typical histological and immunohistochemical characteristics in biopsy of the enlarged right inguinal lymph nodes. The patient initially received 6 cycles of chemotherapy with CHOP regimen (cyclophosphamide, vincristine, adriamycin, prednisone), but his symptoms did not disappear. Nineteen months after initial diagnosis of AITL, the patient was hospitalized again because of multiple plaques and nodules on the skin. The skin biopsy was performed, but this time the tumor was composed of large, polymorphous population of lymphocytes with CD20 and CD79a positive on immunohistochemical staining. The tumor cells were strong positive for EBER by in situ hybridization. The findings of skin biopsy were compatible with EBV-associated DLBCL. CHOP-R chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab) was then administered, resulting in partial response of the disease with pancytopenia and suppression of cellular immunity. To our knowledge, this is the first case of cutaneous EBV-associated DLBCL originated from AITL in Chinese pepole. We suggest the patients with AITL should perform lymph node and skin biopsies regularly in the course of the disease to detect the progression of secondary lymphomas.<\/jats:p>\n          <jats:p>\n            <jats:bold>Virtual slides<\/jats:bold>\n          <\/jats:p>\n          <jats:p>The virtual slide(s) for this article can be found here:<\/jats:p>\n          <jats:p>\n            <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1197421158639299\" ext-link-type=\"uri\">http:\/\/www.diagnosticpathology.diagnomx.eu\/vs\/1197421158639299<\/jats:ext-link>\n          <\/jats:p>","DOI":"10.1186\/1746-1596-7-7","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T19:31:01Z","timestamp":1327001461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature"],"prefix":"10.1186","volume":"7","author":[{"given":"Qing-Xu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Juan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,19]]},"reference":[{"key":"509_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, M\u00fcller-Hermelink HK, Non-Hodgkin's Lymphoma Classification Project: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002, 13: 140-149. 10.1093\/annonc\/mdf033.","journal-title":"Ann Oncol"},{"key":"509_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","volume":"121","author":"A Dogan","year":"2003","unstructured":"Dogan A, Attygalle AD, Kyriakou C: Angioimmunoblastic T-cell lymphoma. Br J Haematol. 2003, 121: 681-691. 10.1046\/j.1365-2141.2003.04335.x.","journal-title":"Br J Haematol"},{"key":"509_CR3","first-page":"309","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"A Dogan","year":"2008","unstructured":"Dogan A, Gaulard P, Jaffe ES, Ralfkiaer E, M\u00fcller-Hermelink HK: Angioimmunoblastic T-cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues. Edited by: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. 2008, Lyon: IARC, 309-311. 4","edition":"4"},{"key":"509_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V82.1.241.bloodjournal821241","volume":"82","author":"LV Abruzzo","year":"1993","unstructured":"Abruzzo LV, Schmidt K, Weiss LM, Jaffe ES, Medeiros LJ, Sander CA, Raffeld M: B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood. 1993, 82: 241-246.","journal-title":"Blood"},{"key":"509_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.thj.6200202","volume":"3","author":"S Park","year":"2002","unstructured":"Park S, Noguera ME, Bri\u00e8re J, Feuillard J, Cayuela JM, Sigaux F, Brice P: Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma. Hematol J. 2002, 3: 317-720. 10.1038\/sj.thj.6200202.","journal-title":"Hematol J"},{"key":"509_CR6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1309\/VD2D-98ME-MB3F-WH34","volume":"118","author":"Y Xu","year":"2002","unstructured":"Xu Y, McKenna RW, Hoang MP, Collins RH, Kroft SH: Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol. 2002, 118: 848-854. 10.1309\/VD2D-98ME-MB3F-WH34.","journal-title":"Am J Clin Pathol"},{"key":"509_CR7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","volume":"117","author":"A Zettl","year":"2002","unstructured":"Zettl A, Lee SS, R\u00fcdiger T, Starostik P, Marino M, Kirchner T, Ott M, M\u00fcller-Hermelink HK, Ott G: Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002, 117: 368-379. 10.1309\/6UTX-GVC0-12ND-JJEU.","journal-title":"Am J Clin Pathol"},{"key":"509_CR8","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.5858\/2006-130-1707-ATLWSE","volume":"130","author":"RC Hawley","year":"2006","unstructured":"Hawley RC, Cankovic M, Zarbo RJ: Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma. Arch Pathol Lab Med. 2006, 130: 1707-1711.","journal-title":"Arch Pathol Lab Med"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","volume":"31","author":"AD Attygalle","year":"2007","unstructured":"Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC, Chuang SS, Cabe\u00e7adas J, Isaacson PG, Du MQ, Gaulard P, Dogan A: Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol. 2007, 31: 1077-1088. 10.1097\/PAS.0b013e31802d68e9.","journal-title":"Am J Surg Pathol"},{"key":"509_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1365-2141.2007.06725.x","volume":"138","author":"K Willenbrock","year":"2007","unstructured":"Willenbrock K, Br\u00e4uninger A, Hansmann ML: Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol. 2007, 138: 733-739. 10.1111\/j.1365-2141.2007.06725.x.","journal-title":"Br J Haematol"},{"key":"509_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12185-008-0176-2","volume":"88","author":"KC Weisel","year":"2008","unstructured":"Weisel KC, Weidmann E, Anagnostopoulos I, Kanz L, Pezzutto A, Subklewe M: Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma. Int J Hematol. 2008, 88: 434-440. 10.1007\/s12185-008-0176-2.","journal-title":"Int J Hematol"},{"key":"509_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3960\/jslrt.50.59","volume":"50","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Maruyama R, Mishima S, Inoue M, Kawakami K, Onishi C, Miyake T, Tanaka J, Nabika T, Ishikura H: Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. J Clin Exp Hematop. 2010, 50: 59-63. 10.3960\/jslrt.50.59.","journal-title":"J Clin Exp Hematop"},{"key":"509_CR13","first-page":"241","volume":"34","author":"ND Skugor","year":"2010","unstructured":"Skugor ND, Peri\u0107 Z, Vrhovac R, Radi\u0107-Kristo D, Kardum-Skelin I, Jaksi\u0107 B: Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol. 2010, 34: 241-245.","journal-title":"Coll Antropol"},{"key":"509_CR14","volume-title":"Diagn Cytopathol","author":"J Huang","year":"2011","unstructured":"Huang J, Zhang PH, Gao YH, Qiu LG: Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Diagn Cytopathol. 2011, doi:10.1002\/dc.21641"},{"key":"509_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","volume":"1","author":"G Frizzera","year":"1974","unstructured":"Frizzera G, Moran EM, Rappaport H: Angioimmunoblastic lymphadenopathy with dysproteinaemia. Lancet. 1974, 1: 1070-1073.","journal-title":"Lancet"},{"key":"509_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/0002-9343(75)90466-0","volume":"59","author":"G Frizzera","year":"1975","unstructured":"Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy: diagnosis and clinical course. Am J Med. 1975, 59: 803-818. 10.1016\/0002-9343(75)90466-0.","journal-title":"Am J Med"},{"key":"509_CR17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1136\/jcp.39.11.1229","volume":"39","author":"NT O'Connor","year":"1986","unstructured":"O'Connor NT, Crick JA, Wainscoat JS, Gatter KC, Stein H, Falini B, Mason DY: Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J Clin Pathol. 1986, 39: 1229-1232. 10.1136\/jcp.39.11.1229.","journal-title":"J Clin Pathol"},{"key":"509_CR18","first-page":"549","volume":"133","author":"AC Feller","year":"1988","unstructured":"Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, Kuse R, Mak TW, Lennert K: Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol. 1988, 133: 549-556.","journal-title":"Am J Pathol"},{"key":"509_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)64770-0","volume":"156","author":"JL Smith","year":"2000","unstructured":"Smith JL, Hodges E, Quin CT, McCarthy KP, Wright DH: Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol. 2000, 156: 661-669. 10.1016\/S0002-9440(10)64770-0.","journal-title":"Am J Pathol"},{"key":"509_CR20","first-page":"1","volume":"3","author":"G Frizzera","year":"1989","unstructured":"Frizzera G, Kaneko Y, Sakurai M: Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions. Leukemia. 1989, 3: 1-5.","journal-title":"Leukemia"},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, Lamant L, Leroy K, Bri\u00e8re J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007, 109: 4952-4963. 10.1182\/blood-2006-10-055145.","journal-title":"Blood"},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood.V99.2.627","volume":"99","author":"A Attygalle","year":"2002","unstructured":"Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ, Isaacson PG, Dogan A: Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002, 99: 627-633. 10.1182\/blood.V99.2.627.","journal-title":"Blood"},{"key":"509_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","volume":"30","author":"DM Dorfman","year":"2006","unstructured":"Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ: Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006, 30: 802-810. 10.1097\/01.pas.0000209855.28282.ce.","journal-title":"Am J Surg Pathol"},{"key":"509_CR24","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","volume":"79","author":"LM Weiss","year":"1992","unstructured":"Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992, 79: 1789-1795.","journal-title":"Blood"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-7-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:20:31Z","timestamp":1630520431000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-7-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-7-7","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,19]]},"assertion":[{"value":"22 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}